Minera Alamos Reports Third Quarter Results, Provides Corporate Updates, and Further Strengthens Management Team

Toronto, Ontario–(Newsfile Corp. – December 1, 2025) – Minera Alamos Inc. (TSXV: MAI) (OTCQX: MAIFF) (“Minera Alamos” or the “Company“) today reported unaudited financial results for the third quarter of 2025 and is also pleased to announce corporate updates and the further strengthening of its management team. Results are presented in Canadian dollars unless otherwise stated. For details […]

Gold X2 Completes Acquisition of Kesselrun Resources Ltd.

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2025) – Gold X2 Mining Inc. (TSXV: AUXX) (OTCQB: GSHRF) (FSE: DF8) (“Gold X2” or the “Company“), is pleased to announce that it has completed the previously announced plan of arrangement (the “Arrangement“) to acquire all the issued and outstanding common shares of Kesselrun Resources Ltd. (“Kesselrun“). The

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results

(NASDAQ:KMTS), KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial results for the second quarter fiscal 2026 ended October 31, 2025. “Revenue is expected to grow by over 50% in the second quarter and continues to exceed our

enCore Energy Appoints Wayne Heili to the Board of Directors; Announces the Retirement of Dr. Dennis Stover

NASDAQ:EUTSXV:EUwww.encoreuranium.com enCore Energy Corp.(NASDAQ: EU) (TSXV: EU) (the “Company” or “enCore”), America's Clean Energy Company™, announced today the appointment of Mr. Wayne Heili to the Company's Board of Directors effective immediately. In addition, Dr. DennisStover has announced his retirement from the Board effective December 31, 2025. Following his retirement from the Board, Dr.Stover will continue

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results GlobeNewswire December 01, 2025 KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial results for the second quarter fiscal 2026 ended October 31, 2025. “Revenue is expected

FitVille Launches the Exova Collection: Footwear Built for Adventure

Why theExova Hiking Collection Is Built to Conquer Every Terrain FitVille is excited to introduce its Exova Collection, featuring the Exova Low Cut Hiking Shoes V1 and Exova Hiking Boots V1. Designed for adventurers who demand comfort, durability, and support, these models are built to tackle tough trails while keeping your feet comfortable and protected.

hyrUP Announces Acquisition of Evolve Partners, Advancing Growth and Executive Search Excellence Nationwide

hyrUP, an award-winning executive search and recruiting firm specializing in Accounting, Finance, Technology, and Operations, announced today that it has acquired Evolve Partners, a national boutique search firm recognized for its strategic, high-touch approach to executive search and recruiting. https://mma.prnewswire.com/media/2823500/hyrUP___Kate_Brogden.jpg “Over the past 14 years, Evolve Partners has built a reputation for helping growth-stage companies

Tune in to Bloomberg TV to watch a New Episode of Advancements on December 6th at 8:00 pm ET

Take an inside look at how technology is solving issues across the business landscape. Watch a new episode of Advancements with Ted Danson, scheduled to air on Saturday, December 6th at 8:00 PM ET. https://mma.prnewswire.com/media/2832013/Advancements___December_6th_Airing.jpg Discover how smart campus technology is elevating the way people plan, manage, maintain, operate, and utilize the built environment. This

Q32 Bio Sells Complement Inhibitor ADX-097

Asset sale further enables Company's strategic focus on advancing bempikibart for alopecia areata — $12 million in upfront and guaranteed near-term milestone payments expected to extend cash runway into the second half of 2027 — Eligible to receive up to a total of $592 million including the $12 million in upfront and near-term payments upon

Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the Piper Sandler 37th Annual Healthcare Conference in a fireside chat on Thursday, December 4, 2025at10:30 a.m. ETinNew York, NY. A live webcast of the fireside chat can be accessed under

Scroll to Top